DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

Fridays vs MEDVi: November 2026 prices compared

As of November 20, 2026, neither Fridays nor MEDVi printed a month-to-month compounded price that applies at the maintenance dose, so this page compares what each did show and how each bills, without a price verdict.

Released · Last reviewed · how we verify

Fridays and MEDVi, measure by measure

Fridays and MEDVi side by side, from each program’s own page read November 20, 2026 (all-in: medication plus any required recurring fee, before tax)
MeasureFridaysMEDVi
Tirzepatide, month to monthfrom $99 (lowest printed: "as low as" with a coupon code; no month-to-month figure)—
Tirzepatide, lowest printed$99 ("as low as" with a coupon code)—
Semaglutide, month to monthfrom $69 (lowest printed: with a coupon code; no month-to-month figure)—
Semaglutide, lowest printed$69 (with a coupon code)—
Dose pricingpriced by dose or not statednot confirmed
Membership or program feenonenot confirmed
Computed score12 of 40 (position 16 of 27)0 of 40 (position 21 of 27)
FDA warning lettersnone listed721455 (2026-02-20)
November 20 readfirst-party read, promotionalnot readable Nov 20

Strengths and limitations: which fits whom

Fridays prints a month-to-month price; confirm whether it changes with the dose before you rely on it for a year. MEDVi cannot be judged on price this month because its page could not be read on November 20, 2026. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.

What changed since August

The first version of this comparison used captures from August 5–10, 2026. The November 20 re-read replaces them; the August figures are kept below as history, dated.

What changed since the August 2026 capture (maintenance-dose all-in figure then; month-to-month all-in figure read November 20, 2026)
ProgramMedicationAugust 5–10, 2026November 20, 2026
Fridaystirzepatide—from $99
Fridayssemaglutide—from $69

Regulatory record

FDA’s warning-letter index lists warning letter 721455 (dated February 20, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to MEDVi; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Check Fridays’s current prices ↗
Check MEDVi’s current prices ↗

Frequently asked

Which is cheaper, Fridays or MEDVi?

Neither printed a comparable month-to-month price on November 20, 2026, so there is no like-for-like answer this month.

Do Fridays and MEDVi charge a membership fee?

Fridays: no membership fee; MEDVi: not confirmed on November 20, 2026. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.

Are Fridays and MEDVi medications FDA-approved?

Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.

Fridays recordFridays alternativesMEDVi recordMEDVi alternativesAll head-to-headsRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.